tiprankstipranks
Trending News
More News >
Piramal Pharma Limited (IN:PPLPHARMA)
:PPLPHARMA
India Market

Piramal Pharma Limited (PPLPHARMA) Income Statement

Compare
2 Followers

Piramal Pharma Limited Income Statement

Last quarter (Q4 2025), Piramal Pharma Limited's total revenue was ₹27.54B, an increase of 7.90% from the same quarter last year. In Q4, Piramal Pharma Limited's net income was ₹1.53B. See Piramal Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 91.51B₹ 81.71B₹ 70.82B₹ 64.72B₹ 29.00B
Gross Profit
₹ 59.20B₹ 49.09B₹ 40.81B₹ 37.91B₹ 16.46B
Operating Expenses
₹ 23.07B₹ 44.16B₹ 40.80B₹ 34.26B₹ 11.65B
Depreciation and Amortization
₹ 7.76B₹ 7.41B₹ 6.77B₹ 5.86B₹ 609.60M
EBITDA
₹ 14.04B₹ 13.67B₹ 8.46B₹ 12.60B₹ 6.11B
Operating Income
₹ 36.12B₹ 4.32B₹ -479.70M₹ 3.65B₹ 4.81B
Other Income/Expenses
₹ -31.97B₹ -2.52B₹ -721.80M₹ 1.20B₹ 2.06B
Pretax Income
₹ 4.15B₹ 1.79B₹ -1.20B₹ 4.85B₹ 6.87B
Net Income
₹ 911.30M₹ 178.20M₹ -1.86B₹ 3.76B₹ 5.71B
Per Share Metrics
Basic EPS
₹ 0.69₹ 0.14₹ -1.54₹ 3.09₹ 4.70
Diluted EPS
₹ 0.68₹ 0.14₹ -1.54₹ 3.09₹ 4.70
Weighted Average Shares Outstanding
1.34B 1.27B 1.21B 1.22B 1.22B
Weighted Average Shares Outstanding (Diluted)
1.34B 1.28B 1.21B 1.22B 1.22B
Currency in INR

Piramal Pharma Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis